ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• 3-Week Database Builds That Withstood FDA Review

  Learn how a lean clinical team deployed global, regulator-ready databases in just three weeks to secure immediate Phase 3 entry and transform reproductive health research.

• Understanding Security And Role-Based Access In An eTMF Platform

  Most unauthorized data breaches enter through doors that already exist. Learn how role-based access can improve security by tailoring access to each user’s needs and responsibilities.

• Simplifying ePRO Data Collection

  The Bring Your Own Device (BYOD) model, supported by Trialkit, is an innovative approach in clinical trials that allows participants to use personal smartphones or tablets for data collection.

• How DCTs Became The New Standard

  See how the core features of DCTs have become the new default clinical trial practices for a variety of therapeutic areas, almost four years after the 2020 pandemic brought about their rise.

• Implementing eSource: A Guide For Operations And Technology Roles

  By recognizing and addressing the challenges associated with eSource integration, research facilities can fully harness its transformative potential, optimizing efficiency and reliability.

• Why The TrialKit Platform License Agreement Changes The Economics Of Clinical Trials

  A platform‑based pricing model removes change‑order friction, enabling predictable budgets and faster study adjustments. It supports operational agility and portfolio‑level efficiency as trials evolve.

• Demystifying AI In Clinical Trials

  AI is revolutionizing clinical trials by improving efficiency and data quality, but success depends on strategy and oversight. Explore practical ways to integrate AI responsibly.

• Deconstructing Central Rating In Clinical Trials

  Analyze several commonly held misconceptions about Central Rating and its ability to ensure data validity and study success in this

• Electronic Data Capture In Clinical Trials: What Needs To Improve?

  Integrated technologies enhance clinical trial support, boosting the potential for quicker time-to-market. Key sponsors and CROs favoring operational efficiency prioritize "holistic study design," involving the integration of technologies (e.g., EDC, eCOA, and IRT) aligned with protocol, as opposed to constructing the study in individual tools.

• Patient-Centric Clinical Trials: The Power Of Choice

  Patient-centric trials, advocated by the FDA, focus on offering choices to improve engagement, diversity, and data quality. Explore how expanding patient choice can benefit clinical trials.